SARS-CoV-2 created in 2003 patent US-2006257852-A1 assigned to CHIRON CORP (US) which was acquired by Novartis (Switzerland manufacturer of generic drug hydroxychloroquine)

US Patent and Trademark Office SARS-CoV-2 is very similar to SARS. What is different is what makes it a novel SARS coronavirus (SARS-CoV). What’s different is a protein that is exclusively found in SARS-CoV-2 genome and not in SARS-CoV. SARS-CoV-2 genome contains the protein ORF10. “In a recent study comparison of the proteins encoded by SARS-CoV-2 with the … Continue reading SARS-CoV-2 created in 2003 patent US-2006257852-A1 assigned to CHIRON CORP (US) which was acquired by Novartis (Switzerland manufacturer of generic drug hydroxychloroquine)